Publications

Browse recent peer reviewed articles reporting the results of Gilead-sponsored Clinical Trials. The list of publications below is limited to products that have been approved for use and may contain information about doses, delivery devices, uses, formulations and populations different from product labeling. Review articles are excluded. Clinical decisions should be based on the full safety and efficacy information contained in the product's Full Prescribing Information in the provide link next to the product name.

If you have questions about a Gilead-sponsored clinical trial not listed below or would like to request an electronic copy of one of the journal publications on this page, please contact Gilead Medical Information below for further assistance.

Product (select up to 3)
Phase
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Select a product to view publications

    Veklury®

    remdesivir 100 mg for injection

    Letairis®

    ambrisentan 5 mg and 10 mg

    Sovaldi®

    sofosbuvir 400 mg

    Viread®

    tenofovir disoproxil fumarate 300 mg

    Vemlidy®

    tenofovir alafenamide 25 mg

    Atripla®

    efavirenz 600 mg/emtricitabine 200 mg/tenofovlr disoproxil fumarate 300 mg

    Truvada®

    emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

    Descovy®

    emtricitabine 200 mg/tenofovir alafenamlde 25 mg

    Biktarvy®

    bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg

    Cayston®

    aztreonam for inhalation solution 75 mg/vial

    Complera®

    emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg

    Emtriva®

    emtricitabine 200 mg

    Epclusa®

    sofosbuvir 400 mg/velpatasvir 100 mg

    Genvoya®

    elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200mg/tenofovir alafenamide 10 mg

    Harvoni®

    ledipasvir 90 mg/sofosbuvir 400 mg

    Hepsera®

    adefovir dipivoxil 10 mg

    Odefsey®

    emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg

    Stribild®

    elvitegravlr 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

    Sunlenca®

    lenacapavir injection 463.5 mg/1.5 mL; lenacapavir tablets 300 mg

    Tecartus®

    brexucabtagene autoleucel

    Trodelvy®

    sacituzumab govitecan-hziy 180 mg for injection

    Tybost®

    cobicistat 150 mg

    Vosevi®

    sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg tablets

    Yescarta®

    axicabtagene ciloleucel

    Zydelig®

    idelalisib 150 mg
    Looking for more publication details?
    Contact Gilead Medical Resource Center
    1-866-MEDI-GSI (1-866-633-4474) | Monday – Friday, 5am – 6pm PT